PLEASE READ THIS NOTICE CAREFULLY - IT APPLIES TO ALL PERSONS WHO VIEW THIS SITE
THESE MATERIALS ARE NOT DIRECTED AT OR INTENDED TO BE ACCESSED BY PERSONS LOCATED OUTSIDE INDIA. THESE MATERIALS ARE BEING MADE AVAILABLE ON THIS WEBSITE TO COMPLY WITH SECURITIES AND EXCHANGE BOARD OF INDIA (ISSUE OF CAPITAL AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2018, AS AMENDED.
Investors should read the Draft Red Herring Prospectus and seek professional advice before taking any action. UBS Securities India Private Limited (“UBS”) does not accept any liability whatsoever direct or indirect that may arise from the use of the information contained in the Draft Red Herring Prospectus.
IMPORTANT: You must read and agree with the terms and conditions of the following disclaimer before continuing.
The following disclaimer applies to the draft red herring prospectus dated August 29, 2025 (“DRHP”) of LEAP India Limited (the “Company”) filed with the Securities and Exchange Board of India (the “SEBI”), BSE Limited (“BSE”) and National Stock Exchange of India Limited (“NSE”, and together with BSE, the “Stock Exchanges”) hosted on this website in connection with the proposed initial public offering of equity shares of face value of ₹1 each (“Equity Shares”) of the Company, by way of a fresh issue of Equity Shares and offer for sale of Equity Shares by the selling shareholders (together, the “Offer”) that UBS is associated as one of the book running lead manager (“BRLM”). The DRHP has been made available on this website in electronic form solely to comply with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (“SEBI ICDR Regulations”). You are advised to read this disclaimer carefully before reading, accessing or making any other use of the DRHP. By accessing the DRHP, you agree to follow the following terms and conditions, including any modifications to them from time to time.
The contents of the DRHP are for your information only and you acknowledge that access to the DRHP is intended for use by you only and you agree not to forward the DRHP on to any other person, internal or external to your company, in whole or in part, or otherwise provide access via e-mail or otherwise to any person. No part of the contents herein shall be copied or duplicated in any form by any means or redistributed. Any person into whose possession the DRHP comes is required to inform himself or herself about and to observe any such restrictions. UBS and/or its affiliates or their respective directors, officers and employees (together, the “Affiliates”) are not soliciting any action based on any of the information contained on this website, including the DRHP, and such information should not be construed as an offer, or invitation or offer to sell or the solicitation of any offer to buy or subscribe for or purchase any security. The DRHP does not amount to, or is intended to be, a prospectus or an offer document, in terms of the Companies Act, 2013, and the SEBI ICDR Regulations, and nothing in the DRHP constitutes an offer or an invitation by or on behalf of either the Company or any of the members of the syndicate to subscribe for or purchase any of the securities described therein. The UBS does not accept any responsibility for any contravention of applicable securities laws and regulations by individuals as a result of false information provided by such individuals. The information contained in the DRHP may not be updated since its original publication date and may not reflect the latest updates. The information is current only as of its date and shall not, under any circumstances, create any implication that the information contained therein is correct as of any time subsequent to the date thereof or that there has been no change in the financial condition or affairs of the Company since such date. This document may be updated from time to time and there is no undertaking by the UBS or any of its affiliates to post any such amendments or supplements on this website.
Please note that because of restrictions imposed by applicable law or regulation on soliciting securities business in various jurisdictions, subscription to the Offer will not be permitted to residents of certain jurisdictions. Accordingly, the Offer related information on this site is not available to all jurisdictions. The DRHP is directed at, and is, intended for distribution to, and use by, residents of India only. The DRHP is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where (a) distribution or use of such information would not be permissible under or in violation of any applicable law or regulation; or (b) UBS or any of its Affiliates would by virtue of such distribution become subject to new or additional registration, licensing or other regulatory requirements.
The Equity Shares offered in the Offer have not been and will not be registered under the U.S. Securities Act, 1933 (“U.S. Securities Act”) or any other applicable law of the U.S. and, unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the U.S. Securities Act and applicable state securities laws. Accordingly, the Equity Shares are being offered and sold (a) within the U.S. only to persons reasonably believed to be “qualified institutional buyers” (as defined in Rule 144A under the U.S. Securities Act and referred to in the Draft Red Herring Prospectus as “U.S. QIBs”; for the avoidance of doubt, the term U.S. QIBs does not refer to a category of institutional investor defined under applicable Indian regulations and referred to in the Draft Red Herring Prospectus as “QIBs”) in transactions exempt from or not subject to the registration requirements of the U.S. Securities Act; and (b) outside the U.S. in offshore transactions as defined in and in compliance with Regulation S and the applicable laws of the jurisdiction where those offers and sales are made.
Any potential investor should note that investment in equity shares involves a high degree of risk. For details, potential investors should refer to the red herring prospectus, including the section titled “Risk Factors”, when available. Any decision on whether to invest in the equity shares described in the DRHP may only be made after a red herring prospectus has been filed with the Registrar of Companies, Maharashtra at Mumbai (“RoC”), and must be made solely on the basis of the red herring prospectus proposed to be filed with the RoC. Potential investors should not rely on the DRHP filed with SEBI and the Stock Exchanges.
UBS, one of the BRLMs has taken all necessary steps to ensure that the contents of the DRHP as appearing on this website are identical to the DRHP filed with SEBI and the Stock Exchanges, in accordance with the SEBI ICDR Regulations. However, you are reminded that documents transmitted in electronic form may be altered or changed during the process of transmission and consequently neither UBS nor any of its Affiliates accept any liability or responsibility whatsoever in respect of alterations or changes which have taken place during the course of transmission of electronic data. Neither UBS nor any of its Affiliates will be responsible for any loss or damage that could result from interception and interpretation by any third parties of any information being made available to you through this website.
Neither UBS, nor any of its Affiliates nor their directors, officers and employees will be liable or have any responsibility of any kind for any loss or damage that you incur in the event of any failure or disruption of this website, or resulting from the act or omission of any other party involved in producing or hosting this website or the data contained therein available to you, or from any other cause relating to your access to, inability to access or use of the website or these materials.
IF YOU ARE NOT PERMITTED TO VIEW MATERIALS ON THIS WEBSITE OR ARE IN ANY DOUBT AS TO WHETHER YOU ARE PERMITTED TO VIEW THESE MATERIALS, PLEASE EXIT THIS WEBPAGE.
Please note that forms downloaded and used for subscription to the Offer in contravention of the above will be rejected with no recourse to UBS, the Company, or any of their respective Affiliates.
I have read the Legal Disclaimer and am entitled to receive information contained in this website.